Related references
Note: Only part of the references are listed.Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction
Kathryn A. Cunningham et al.
NEUROPHARMACOLOGY (2014)
The Heffter Research Institute: Past and Hopeful Future
David E. Nichols
JOURNAL OF PSYCHOACTIVE DRUGS (2014)
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Robin L. Carhart-Harris et al.
SCHIZOPHRENIA BULLETIN (2013)
A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment
Brittany Vasae Burdick et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2013)
Serotonin receptor, SERT mRNA and correlations with symptoms in males with alcohol dependence and suicide
P. M. Thompson et al.
ACTA PSYCHIATRICA SCANDINAVICA (2012)
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
Michael Kometer et al.
BIOLOGICAL PSYCHIATRY (2012)
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
Matthew W. Johnson et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
Michael P. Bogenschutz et al.
DRUG TESTING AND ANALYSIS (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies
Stephen Ross
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Increased Serotonin 2A Receptor Availability in the Orbitofrontal Cortex of Physically Aggressive Personality Disordered Patients
Daniel R. Rosell et al.
BIOLOGICAL PSYCHIATRY (2010)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Decreased cerebral cortex and liver 5-HT2A receptor gene expression and enhanced ALDH activity in ethanol-treated rats and hepatocyte cultures
Akash K. George et al.
NEUROLOGICAL RESEARCH (2010)
Role of BDNF and GDNF in drug reward and relapse: A review
Udi E. Ghitza et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Psychedelics and the Human Receptorome
Thomas S. Ray
PLOS ONE (2010)
ELEVATED 5-HT 2A RECEPTORS IN POSTMORTEM PREFRONTAL CORTEX IN MAJOR DEPRESSION IS ASSOCIATED WITH REDUCED ACTIVITY OF PROTEIN KINASE A
R. C. Shelton et al.
NEUROSCIENCE (2009)
Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling
Kelly A. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex
Mark D. Underwood et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Bankole A. Johnson
BIOCHEMICAL PHARMACOLOGY (2008)
Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder
Vibe G. Frokjaer et al.
BIOLOGICAL PSYCHIATRY (2008)
Enhanced 5-HT2A Receptor Status in the Hypothalamus and Corpus Striatum of Ethanol-Treated Rats
K. G. Akash et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2008)
Enhanced dopamine D2 receptor function in hypothalamus and corpus striatum:: their role in liver, plasma and in vitro hepatocyte ALDH regulation in ethahol treated rats
K. G. Akash et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells
Mami Tsuchioka et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
5HT2A receptor binding is increased in borderline personality disorder
Paul H. Soloff et al.
BIOLOGICAL PSYCHIATRY (2007)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
'Hitting highs at rock bottom': LSD treatment for alcoholism, 1950-1970
Erika Dyck
SOCIAL HISTORY OF MEDICINE (2006)
Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex
PJ Gresch et al.
NEUROPSYCHOPHARMACOLOGY (2005)
The NEO-PI-3: A more readable revised NEO Personality Inventory
RR McCrae et al.
JOURNAL OF PERSONALITY ASSESSMENT (2005)
Assessing competence in the use of motivational interviewing
TB Moyers et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2005)
De profundis: Spiritual transformations in alcoholics anonymous
AA Forcehimes
JOURNAL OF CLINICAL PSYCHOLOGY (2004)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Share Paper
